In the past decades, nanoparticles have attracted increasing attention in biomedicine field due to their high drug-loading effectiveness, well selectivity for target tissues, and long-acting time in circulation. Among them, drug delivery system based on protein nanoparticles has been widely studied aiming to overcome deficiency of drug-loaded materials, such as low biocompatibility, inefficient biodegradability and high toxicity. In this review, we briefly introduced the drug delivery system based on protein nanoparticles. The methods for synthesizing protein nanoparticles as well as its therapeutic efficacy as drug delivery system were considered. And we also discussed the application and prospects of protein nanoparticles in drug delivery.
Introduction
Recently, much attention has been attracted on exploring nanoparticles as drug delivery materials, which aims to overcome the following challenges: 1) Large doses of organic solvents should be used for loading some anti-cancer drugs, such as doxorubicin, paclitaxel and cisplatin, due to its poor solubility in aqueous solution, which may leading to the toxicity for the drug delivery system; 2) high side-effect of many drugs due to their low efficiency in targeting to specific tissue and cells; 3) very short acting time in circulation for many drugs (1) (2) (3) (4) (5) (6) some challenges in preparing these drug-loaded nanoparticles and increasing the drug-loading efficiency. And the therapeutic efficiency also limited by the toxicity of drugs for health tissues and cells due to the low tumor-targeting efficiency (13, 14) . Liposomes have been used as potential drug delivery carriers due to its advantages in protecting drugs from degradation, targeting to special tissue and decreasing the toxicity or side effects (15) . However, the application of liposome is limited due to its inherent problems, such as low encapsulation efficiency, rapid release rate of hydrophilic drugs in serum and poor stability for its storage (15) . Besides, many other biomaterials, such as organic polymers, proteins and silica, have been developed as drug carries (16) (17) (18) . Each biomaterial was found to be available due to some of its advantage characters, while it usually has some disadvantages in other fields. Among these available biomaterials as potential drug carrier systems, protein-based nanoparticles that synthesized by variety of natural proteins and engineered synthetic polypeptides, has very promising potential for drug delivery (19) . Having the brilliant characters of biocompatibility, biodegradability and low toxicity, the proteinbased NPs are naturally self-assembled protein subunits of the same protein or a combination of proteins making up a complete system (20, 21) . And proteins can offer a lot of moieties which are accessible to modify little molecules for drug-binding, imaging or targeting entities (22, 23) . Due to the great quickly development of nanotechnology recently, the preparation of protein-based NPs has been focused on many proteins, such as albumin, gelatin, gliadin and legumin. Based on the previous studies, we proposed that the protein-based nanoparticles have more potential applications in drug delivery in the future. Thus, in this review, we aim to discuss the fabrication of proteinbased NPs and its applications in drug delivery.
Synthesis of protein-based nanoparticles
Up to now, people have paid attentions on the synthesis of nanoparticles and many methods including sonochemistry, colloidal method, thermal decomposition, hydrothermal method, and microemulsion method (24) (25) (26) , have been developed for synthesizing nanoparticles as drug delivery carriers for earlier diagnosis and treatment of some diseases. However, many of these methods were always limited by the toxicity of drugs for normal cells and tissue due to the difficulty of loading hydrophobic agents for administration (27) (28) (29) . There are two major developed pathways for synthesis of protein nanoparticles: through crosslinking with functional groups of native protein molecules or the derivative groups modified on the surface of protein molecules (30, 31) .
The coacervation or equally coined desolvation process under relatively mild conditions is one of the most frequent methods to prepare protein-based NPs. In general, the protein solvent was extracted into an anti-solvent phase to make a colloidal system (32, 33) . And the following phase separation leads to the solid colloid phase that dispersed in another phase with the initial protein dissolved solvent and an anti-solvent. And then the anti-solvent and the initial solvent should be miscible (34) (35) (36) . The size and output of protein nanoparticles are determined by the pH value of the solution prior to desolvation (37) .
Recently, people developed electrospray as a new technique for synthesis of protein nanoparticles. And this method has been used for synthesis of gliadin and elastin-like protein nanoparticles (38, 39) . In general, high voltage was used on the solution with an emitter. The sizes of protein nanoparticles which contained by the emitted aerosolized droplets can be well controlled. And the therapeutic drugs and nucleic acids can be well loaded by the protein nanoparticles with high efficacy through this pathway.
Although the synthesis methods of protein-based nanoparticles has been widely improved, the costly, toxicity chemical reagents introduction, and the difficulty in size controllable are still significant challenges in synthesis of protein-based NPs, thus greatly limits its application in biomedicine field (Table 2) . Reducing the disulfide bonds of native proteins by UV illumination and thus inducing the self-assembly into protein nanoparticles is a potential good pathway to solve these problems. Prompers et al. firstly reported that the disulfide bonds in protein molecules can be broken by UV illumination (40) . The tryptophans (Trp) residues neighbing disulfide bonds were thought to be responsible to this photo-reduction. Petersen et al. found that the quantum of free thiols in cutinase was increased after being illuminated by UV light (41) . And Hanssens et al. found the similar photo-reduction phenomenon in another protein of goat α-lactalbumin (42). Xie et al. systemly studied the unfolding mechanism of lysozyme under UV illumination and they found that these proteins can self-assemble into protein nanoparticles only through UV illumination. Besides, both the size and morphology of these protein nanoparticles can be well controlled with changing the illumination time or intensity of UV light.
The application of protein-based nanoparticles in drug delivery
Protein-based nanoparticles have been widely used as drug delivery system (12) . Here, we introduce several examples about the application of protein nanoparticles in drug delivery. Silk protein was reported as carries for gene delivery in vitro (43, 44) . Many kinds of cytostatic drugs, such as 5-fluorouracil, paclitaxel and doxorubicin (DOX) have been reported for binding to albumin and thus si- gnificantly enhanced the anti-tumor efficacy (45) (46) (47) . And the toxicity of these drugs was greatly decreased by loading into the protein-based NPs (48) . Gelatin was used in increasing the cellular responsive to foreign antigen as a kind of immunological adjuvant (49) . Albumin, such as ovalbumin and serum albumin (BSA and HSA), is a major protein in the circulation system. Albumin has very important functions in controlling osmotic pressure and loading nutrients to tissues and cells. Albumin acts as a depot and transportation protein for delivery many therapeutic drugs and endogenous molecules. [13] Albumin is very stable under the pH from 4 to 9 and can bear temperature of 60 o C for 10 hours without unfolding (14) . And the albumin is widely used in synthesis of nanospheres and nanocapsules for drug delivery due to its biodegradable, easy synthesis, and well-controlled sizes and easy modification for its function groups on the surface of molecular. Besides, the loaded drug can be released from albumin nanoparticles easily by protease digestion (15) . Albumin-bound NPs (nab) has been used to carry hydrophobic molecules and it can come into bloodstream through the pathway of endogenous albumin (50), avoiding the solvent-based toxicities for bodies. Besides, the albumin-bound paclitaxel has been investigated in reducing the risk of hypersensivity reactions without premedication and special intravenous tubing (51, 52) . Two Human serum albumin (HAS) based drugs, Abraxane and Albunex, have been tested having great clinical benefits and has been used on the market for many years (53, 54) .
Elastinlike polypeptide (ELP) has been used for tissue targeting due to its environment-responsive character. The cell-penetrating peptides (CPPs) have been widely used in drug delivery (55) . That is one of cell-penetrating peptides and has been reported as a carries for many proteins crossing over cell membranes (56) . And the study of in vivo delivery of Fab fragments conjugated with Tat as previously reported shown that the Tat peptide has well special tissue localization (57) .
Based on the photo-reduction mechanism, Xie et al. developed a one-step method to synthesize anticancer drugs loaded protein nanoparticles upon UV illumination (shown in Figure 1 ). This synthesis method was performed without adding any toxicity organic solvents or chemical denaturants. Besides, it was reported that these protein-nanoparticles showed rapid rate for drug release under acidic and reducing conditions while slowly at physiological environment, suggesting that these protein nanoparticles are suitable for anti-tumor drug delivery.
The result of in vivo experimental suggested that the RGD-conjugated protein nanoparticles have great affection on tumor targeting and inhibition (figure 3). And this method of synthesis of protein nanoparticles based on photo-reduction can be extended to synthesize many other disulfide-containing protein-based nanoparticles for drug delivery, although some challenge for this photo-reduction method, such as the potential decomposition for some drugs under high intensity of UV light illumination and the low drug-loading efficiently has to be overcome.
Conclutions
Protein, including variety of natural proteins and engineered synthetic polypeptides, based platforms of biomaterials has very promising potential for drug delivery. Many synthesis methods for protein nanoparticles were developed. And the protein characters of biodegradability, biocompatibility, and even the effect of particles sizes act significant roles on the application of protein nanoparticles in drug delivery. Protein nanocarriers have great potential application to the future development of anti-cancer therapeutics due to its high loading efficiency and targeting effect.
And synthesizing methods will be further developed to further improve delivery of anti-cancer drugs, siRNA, and other therapeutic molecules by using protein nanocarriers. And synthesis of multi-funtional protein nanoparticles for drug delivery will be another potential direction in biomedicine. This review offers a whole summary about the synthesis, characters as well as the application of protein nanoparticles as drug delivery system and we hope that this will be a useful reference in the further development of protein nanotechnology.
